SOLVE Research & Consultancy

SOLVE Research & Consultancy

Stockholm, Sweden· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

SOLVE Research & Consultancy operates as a specialized contract research organization (CRO) focused on high-resolution analytical services for the biopharmaceutical and nanotechnology sectors. Its core expertise lies in sophisticated separation and characterization techniques, particularly FFF-MALS, which it claims to be the world's leading contract lab for. The company provides essential support for drug development, formulation, and quality control, helping clients characterize complex samples like proteins, antibodies, viruses, and nanomedicines. By offering consulting and method development alongside analysis, SOLVE positions itself as a scientific partner rather than just a service provider.

AI / Machine LearningDrug Delivery

Technology Platform

Expert application of advanced biophysical characterization techniques including Field-Flow Fractionation (FFF), Multi-Angle Light Scattering (MALS), Size-Exclusion Chromatography (SEC), Analytical Ultracentrifugation (AUC), and Dynamic Light Scattering (DLS). Specializes in coupling these techniques (e.g., FFF-MALS, SEC-MALS) and pioneering novel on-line couplings like FFF to Small-Angle X-ray Scattering (SAXS) for comprehensive analysis of proteins and nanoparticles in complex matrices.

Opportunities

Growing demand for characterization of complex biologics, gene therapies, and nanomedicines drives need for sophisticated analytical services like FFF-MALS.
Pioneering novel technique couplings (e.g., AF4-SAXS) creates a competitive moat and allows entry into new, high-value application areas.
Expansion of services into data analysis, informatics, and regulatory support could increase client engagement and revenue per project.

Risk Factors

Revenue is tied to client R&D budgets, making it vulnerable to downturns in biotech funding.
Competition from other specialized CROs and in-house capabilities at large pharma companies is intense.
The business is highly dependent on retaining a small number of expert scientists, creating key-person risk and scalability challenges.

Competitive Landscape

SOLVE competes in the niche market for high-end biophysical characterization. Competitors include other specialist CROs focusing on techniques like AUC or light scattering, as well as the analytical services divisions of large, global CROs. Its main differentiation is its claimed leadership in FFF-MALS contract services and its proven ability to develop and apply cutting-edge, multi-technique couplings that many labs cannot offer.